Malaria caused 597,000 deaths worldwide in 2023, with children under 5 accounting for 76 percent of all malaria deaths in the ...

Novartis said on Tuesday it had received approval in Switzerland for Coartem Baby, which it said was the first drug to treat ...

The approval of the first malaria treatment for newborns and young infants could lead to imminent widespread use in Africa, ...

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...

The U.S. Food and Drug Administration approved "Spikevax," Moderna's vaccine for children aged 6 months to 11 years old. The ...

Medicare drug plans will likely cover generic famotidine, and some Medicare Advantage plans will cover OTC famotidine. Learn more about coverage and costs.

A new malaria treatment has been approved for newborns and infants under 11 pounds, filling a major gap in care.

FDA approves ENFLONSIA, a long-acting monoclonal antibody to protect infants from RSV-related lung disease through their first winter with a single fixed-dose shot.

CDC advisers recommend Merck's Enflonsia to protect babies from RSV, addressing the leading cause of infant hospitalization ...

CDC advisers recommend Merck's Enflonsia to protect babies from RSV, addressing the leading cause of infant hospitalization ...